| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-08 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-08 |